Clinical Efficacy of Conservative Treatment in Female Patients With Plevic Congestion Syndrome

Clinical Efficacy of Conservative Treatment in Female Patients With Plevic Congestion Syndrome

The article presents the results of a randomized, placebo-controlled study of the conservative treatment with Daflon (Detralex) in female patients with Pelvic congestion syndrome .

Inclusion Criteria:

•The presence of pelvic varicose veins verified by transvaginal and transabdominal duplex ultrasound scanning

Exclusion Criteria:

• Severe disease of the gastrointestinal tract or hematopoietic system
• Terminal stage of cardiovascular, respiratory, renal or hepatic failure
• Grade IV malignancy
• Peripheral artery disease (PAD) of the lower extremities, any type of diabetes, or mental disease.
• Pregnant women at any gestational age, women who gave birth less than 12 months ago, and breastfeeding mothers.